J D Bitran|J E Ultmann - JoVE Visualize

Showing results (81-90 of 125) with videos related to

Pageof 13

Sort By:

Cancer|February 1, 1983

Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyJ D Bitran, R K Desser, C M Shapiro, et al.

American Journal of Clinical Oncology|October 1, 1992

The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancerW J Gradishar, R Mick, P C Hoffman, et al.

Cancer|May 1, 1982

Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastasesE Robin, J D Bitran, H M Golomb, et al.

Bone Marrow Transplantation|February 1, 1996

Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancerJ D Bitran, B Samuels, L Klein, et al.

Seminars in Oncology|April 1, 1995

Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancerL C Drinkard, P C Hoffman, B L Samuels, et al.

Cancer Treatment Reports|April 1, 1982

Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative studyR S Stein, H M Golomb, P H Wiernik, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985

Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980)M A Cornbleet, U Vitolo, J E Ultmann, et al.

Annals of Internal Medicine|February 1, 1980

Anatomic substages of stage III-A Hodgkin's disease. A collaborative studyR S Stein, H M Golomb, C H Diggs, et al.

International Journal of Radiation Oncology, Biology, Physics|October 1, 1989

Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapyR Farah, H M Golomb, D E Hallahan, et al.

Experimental Hematology|June 1, 1996

A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cellsS Roman-Unfer, J D Bitran, L Garrison, et al.

Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:

Pageof 13

Cancer|February 1, 1983

Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyJ D Bitran, R K Desser, C M Shapiro, et al.

American Journal of Clinical Oncology|October 1, 1992

The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancerW J Gradishar, R Mick, P C Hoffman, et al.

Cancer|May 1, 1982

Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastasesE Robin, J D Bitran, H M Golomb, et al.

Bone Marrow Transplantation|February 1, 1996

Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancerJ D Bitran, B Samuels, L Klein, et al.

Seminars in Oncology|April 1, 1995

Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancerL C Drinkard, P C Hoffman, B L Samuels, et al.

Cancer Treatment Reports|April 1, 1982

Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative studyR S Stein, H M Golomb, P H Wiernik, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985

Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980)M A Cornbleet, U Vitolo, J E Ultmann, et al.

Annals of Internal Medicine|February 1, 1980

Anatomic substages of stage III-A Hodgkin's disease. A collaborative studyR S Stein, H M Golomb, C H Diggs, et al.

International Journal of Radiation Oncology, Biology, Physics|October 1, 1989

Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapyR Farah, H M Golomb, D E Hallahan, et al.

Experimental Hematology|June 1, 1996

A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cellsS Roman-Unfer, J D Bitran, L Garrison, et al.

Pageof 13